Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02114515 · ClinicalTrials.gov registry record · NA

PATient Navigator to rEduce Readmissions

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
1,029
Enrollment target

NCT02114515: Completed NA study, sponsored by University of Illinois at Chicago.

NCT02114515 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 1,029 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02114515, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
1,029 participants
Enrollment target

Study Summary

Staying out of the hospital is valued by patients and their caregivers. Their interests converge with those of hospitals now that high 30-day readmission rates for some conditions place hospitals at risk for financial penalties from the Centers for Medicare and Medicaid Services. This study focuses on developing and testing a program that combines a community health worker (lay patient advocate, acting as a "Patient Navigator") and a peer-led telephone support line to improve patient experience during hospital to home transition.

Primary Outcome

Change in T-score from baseline to 30 days post discharge (30 days minus baseline). A change in t-score \<0 indicates improvement. A change equal to 0 indicates no change. A change \>0 indicates worsening.

Interventions

  • BEHAVIORAL Hospital usual care
  • BEHAVIORAL Navigator intervention
  • BEHAVIORAL Peer-led telephone support line

Trial Details

FieldValue
Enrollment Target 1,029 participants
Start Date 2014-07
Est. Completion 2016-10
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT02114515 record still lists

NCT02114515 is an interventional study that assigns participants to a tested intervention. Its 1,029 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% lower).

The record links to 0 conditions, and to 3 interventions - of which Hospital usual care is the first listed.

NCT02114515 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02114515 about?

NCT02114515 is a clinical study titled "PATient Navigator to rEduce Readmissions". Staying out of the hospital is valued by patients and their caregivers. Their interests converge with those of hospitals now that high 30-day readmission rates for some conditions place hospitals at risk for financial penalties from the Centers for Medicare and Medicaid Services. This study focuses ...

What is the current status of trial NCT02114515?

This trial is currently completed. It is a NA study. The enrollment target is 1,029 participants. The study started on 2014-07. Estimated completion is 2016-10.

What interventions are being tested in trial NCT02114515?

The interventions under investigation include: Hospital usual care (BEHAVIORAL), Navigator intervention (BEHAVIORAL), Peer-led telephone support line (BEHAVIORAL).

Who is sponsoring clinical trial NCT02114515?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02114515's enrollment target sits among peer trials

1,029 104th of 2000 higher than 1,897 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06080698 · 1,030 participants · NA

    Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

  • NCT07084363 · 1,032 participants · NA

    Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

  • NCT02200276 · 1,025 participants · NA

    Influenza Immunization in Adults Over Age 75

  • NCT02296450 · 1,025 participants

    Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02114515, the US trial registry maintained by the National Library of Medicine. NCT02114515 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.